Elotuzumab

Generic Name
Elotuzumab
Brand Names
Empliciti
Drug Type
Biotech
Chemical Formula
-
CAS Number
915296-00-3
Unique Ingredient Identifier
1351PE5UGS
Background

Elotuzumab is a humanized IgG1 (Immunoglobulin G) monoclonal antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies. Elotuzumab targets SLAMF7, also known as Signaling Lymphocytic Activation Molecule Family member 7, a cell surface glycoprotein. ...

Indication

Indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies.

Associated Conditions
Refractory Multiple Myeloma
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath